Operose Advisors’s Carter's CRI Stock Holding History

Operose Advisors’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-250	Closed	-$17.3K	–	633
2023 Q3	$17.3K	Hold	250	–	–	0.01%	492
2023 Q2	$18.1K	Sell	250 -550	-69%	-$37.2K	0.01%	242
2023 Q1	$57.5K	Buy	+800	New	+$61.2K	0.03%	148

Other funds holding CRI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Operose Advisors's CRI Position: Q4 2023 in Review

Operose Advisors sold out of Carter's (CRI) in Q4 2023, closing a stake of 250 shares — an estimated $17.3K sold.

Operose Advisors first reported a position in CRI in Q1 2023 and held it in 3 quarters. The position peaked at $57.5K in Q1 2023. 320 funds tracked by Wall St. Rank hold CRI as of Q4 2023.

Operose Advisors reported no remaining Carter's position as of Q4 2023 after selling out during the quarter.
Operose Advisors sold 250 Carter's shares in Q4 2023, an estimated $17.3K.
Operose Advisors first reported a position in Carter's in Q1 2023 and held it in 3 quarters.
Operose Advisors's Carter's position peaked at $57.5K in Q1 2023.
320 funds tracked by Wall St. Rank held Carter's as of Q4 2023.

Based on Operose Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.